Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > PR's just don't seem to make a difference

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Jul 05, 2023 12:01pm

132 Views

Post# 35527430

RE:PR's just don't seem to make a difference

Yeah I expected no share price movement on this. If it was all of the US or another major country maybe. It all adds up though and will it will be reflected in third quarter QAPs results since it already shipped. Based on last year should be out second week of august likely.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?